CL2004000761A1 - Compuestos derivados de benzotiazol sustituidos con dioxano, ligandos de receptores de adenosina, con afinidad con los receptores a2a, a1 y a3; composicion farmaceutica; procedimiento de preparacion; y uso de los compuestos en el tratamiento de la re - Google Patents
Compuestos derivados de benzotiazol sustituidos con dioxano, ligandos de receptores de adenosina, con afinidad con los receptores a2a, a1 y a3; composicion farmaceutica; procedimiento de preparacion; y uso de los compuestos en el tratamiento de la reInfo
- Publication number
- CL2004000761A1 CL2004000761A1 CL200400761A CL2004000761A CL2004000761A1 CL 2004000761 A1 CL2004000761 A1 CL 2004000761A1 CL 200400761 A CL200400761 A CL 200400761A CL 2004000761 A CL2004000761 A CL 2004000761A CL 2004000761 A1 CL2004000761 A1 CL 2004000761A1
- Authority
- CL
- Chile
- Prior art keywords
- compounds
- ligandos
- benzotiazol
- dioxane
- receivers
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical group C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 title 1
- 102000009346 Adenosine receptors Human genes 0.000 title 1
- 108050000203 Adenosine receptors Proteins 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03008038 | 2003-04-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2004000761A1 true CL2004000761A1 (es) | 2005-02-04 |
Family
ID=33104055
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL200400761A CL2004000761A1 (es) | 2003-04-14 | 2004-04-08 | Compuestos derivados de benzotiazol sustituidos con dioxano, ligandos de receptores de adenosina, con afinidad con los receptores a2a, a1 y a3; composicion farmaceutica; procedimiento de preparacion; y uso de los compuestos en el tratamiento de la re |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US6872833B2 (es) |
| EP (1) | EP1615919B1 (es) |
| JP (1) | JP4426569B2 (es) |
| KR (1) | KR100700422B1 (es) |
| CN (1) | CN100447140C (es) |
| AR (1) | AR043845A1 (es) |
| AT (1) | ATE370947T1 (es) |
| AU (1) | AU2004228193B2 (es) |
| BR (1) | BRPI0409402A (es) |
| CA (1) | CA2520852C (es) |
| CL (1) | CL2004000761A1 (es) |
| CO (1) | CO5640107A2 (es) |
| DE (1) | DE602004008447T2 (es) |
| ES (1) | ES2291868T3 (es) |
| MX (1) | MXPA05011102A (es) |
| NO (1) | NO20054794L (es) |
| RU (1) | RU2005135154A (es) |
| TW (1) | TW200427685A (es) |
| WO (1) | WO2004089949A1 (es) |
| ZA (1) | ZA200508180B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2581454A1 (en) * | 2004-09-23 | 2006-03-30 | Reddy Us Therapeutics, Inc. | Novel pyrimidine compounds, process for their preparation and compositions containing them |
| US7756037B2 (en) * | 2006-08-14 | 2010-07-13 | Cisco Technology, Inc. | Oversubscription of guaranteed bandwidth |
| DE102011005232A1 (de) | 2011-03-08 | 2012-09-13 | AristoCon GmbH & Co. KG | Adenosin und seine Derivate zur Verwendung in der Schmerztherapie |
| CA2903572A1 (en) * | 2013-03-15 | 2014-10-23 | Epizyme, Inc. | Substituted benzene compounds |
| US9243001B2 (en) | 2013-03-15 | 2016-01-26 | Epizyme, Inc. | Substituted benzene compounds |
| PT3661941T (pt) * | 2017-08-01 | 2023-03-16 | Merck Patent Gmbh | Derivados tiazolopiridina como antagonistas do recetor de adenosina |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001281817B2 (en) | 2000-06-21 | 2005-11-24 | F. Hoffmann-La Roche Ag | Benzothiazole derivatives |
| EP1491541B1 (en) * | 2001-03-30 | 2007-01-24 | Pfizer Products Inc. | Pyridazinone aldose reductase inhibitors |
| US6620811B2 (en) | 2001-11-19 | 2003-09-16 | Hoffmann-La Roche Inc. | Isonicotin- and nicotinamide derivatives of benzothiazoles |
| US6734179B2 (en) | 2001-12-12 | 2004-05-11 | Hoffmann-La Roche Inc. | Benzothiazoles |
-
2004
- 2004-03-30 US US10/812,736 patent/US6872833B2/en not_active Expired - Fee Related
- 2004-04-07 MX MXPA05011102A patent/MXPA05011102A/es active IP Right Grant
- 2004-04-07 JP JP2006505050A patent/JP4426569B2/ja not_active Expired - Fee Related
- 2004-04-07 KR KR1020057019469A patent/KR100700422B1/ko not_active Expired - Fee Related
- 2004-04-07 BR BRPI0409402-6A patent/BRPI0409402A/pt not_active IP Right Cessation
- 2004-04-07 CN CNB2004800098019A patent/CN100447140C/zh not_active Expired - Fee Related
- 2004-04-07 ES ES04726119T patent/ES2291868T3/es not_active Expired - Lifetime
- 2004-04-07 EP EP04726119A patent/EP1615919B1/en not_active Expired - Lifetime
- 2004-04-07 TW TW093109634A patent/TW200427685A/zh unknown
- 2004-04-07 RU RU2005135154/04A patent/RU2005135154A/ru not_active Application Discontinuation
- 2004-04-07 DE DE602004008447T patent/DE602004008447T2/de not_active Expired - Lifetime
- 2004-04-07 AU AU2004228193A patent/AU2004228193B2/en not_active Ceased
- 2004-04-07 WO PCT/EP2004/003734 patent/WO2004089949A1/en not_active Ceased
- 2004-04-07 CA CA2520852A patent/CA2520852C/en not_active Expired - Fee Related
- 2004-04-07 AT AT04726119T patent/ATE370947T1/de active
- 2004-04-08 CL CL200400761A patent/CL2004000761A1/es unknown
- 2004-04-12 AR ARP040101209A patent/AR043845A1/es not_active Application Discontinuation
-
2005
- 2005-10-10 ZA ZA200508180A patent/ZA200508180B/en unknown
- 2005-10-11 CO CO05103899A patent/CO5640107A2/es not_active Application Discontinuation
- 2005-10-18 NO NO20054794A patent/NO20054794L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004089949A1 (en) | 2004-10-21 |
| EP1615919A1 (en) | 2006-01-18 |
| EP1615919B1 (en) | 2007-08-22 |
| JP4426569B2 (ja) | 2010-03-03 |
| US6872833B2 (en) | 2005-03-29 |
| CA2520852C (en) | 2011-10-11 |
| RU2005135154A (ru) | 2006-06-27 |
| ATE370947T1 (de) | 2007-09-15 |
| US20040204584A1 (en) | 2004-10-14 |
| CN1774437A (zh) | 2006-05-17 |
| AR043845A1 (es) | 2005-08-17 |
| KR100700422B1 (ko) | 2007-03-28 |
| ES2291868T3 (es) | 2008-03-01 |
| DE602004008447D1 (de) | 2007-10-04 |
| NO20054794L (no) | 2005-10-27 |
| CA2520852A1 (en) | 2004-10-21 |
| DE602004008447T2 (de) | 2008-05-21 |
| AU2004228193B2 (en) | 2009-07-23 |
| ZA200508180B (en) | 2007-03-28 |
| TW200427685A (en) | 2004-12-16 |
| CN100447140C (zh) | 2008-12-31 |
| AU2004228193A1 (en) | 2004-10-21 |
| BRPI0409402A (pt) | 2006-04-25 |
| JP2006522765A (ja) | 2006-10-05 |
| MXPA05011102A (es) | 2005-12-12 |
| KR20050111795A (ko) | 2005-11-28 |
| CO5640107A2 (es) | 2006-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PA8637601A1 (es) | Compuestos moduladores de la actividad de c-kit y usos de los mismos | |
| ATE461932T1 (de) | Pyrazoloä4,3-eü-1,2,4-triazoloä1,5-cüpyrimidine als antagonisten des adenosin-a2a-rezeptors | |
| CL2003002287A1 (es) | COMPUESTOS DERIVADOS DE TIENO[3,2-b]-PIRIDINA-6-CARBONITRILOS Y TIENEO[2,3-b]-PIRIDINA-5-CARBONITRILOS, COMPOSICION FARMACEUTICA, PROCEDIMIENTO DE PREPARACION Y COMPUESTOS INTERMEDIARIOS, Y SU USO EN EL TRATAMIENTO DEL CANCER, APOPLEJIA, OSTEOPOROSIS | |
| CL2008001920A1 (es) | Composicion farmaceutica que comprende un inhibidor de la pde 2, un agonista del receptor selectivo e2 y un portador; y uso en el tratamiento de fractura y/o defecto oseo (div. sol. 3179-04). | |
| CR10583A (es) | Derivados de 1-(-d glucopiranosil)-3-(4-ciclopropilfenilmetil)-4-halogeno indol y uso de los mismos como inhibidores de los transportadores de glucosa dependientes de sodio | |
| HUP0401777A3 (en) | 3h-[1,2,4]triazolo[5,1-i]purin-5-yl amines as adenosine a2a receptor antagonists and pharmaceutical compositions containing the compounds | |
| BRPI0407773B1 (pt) | preparaÇço e uso de composiÇço catalisadora | |
| ECSP088324A (es) | 2-amino-7,8-dihidro-6h-pirido[4,3-d]pirimidina-5-onas | |
| NO20054905D0 (no) | 2-acylamino-4-fenyltiazolderivater, fremgangsmate for deres fremstilling og anvendelse av de samme som i terapeutika | |
| BRPI0614205A2 (pt) | composto, composição farmacêutica, e, uso de composto | |
| UY27760A1 (es) | Nuevos derivados de pirrolidinio. | |
| EE200300594A (et) | (1-bensüül-4-metüülpiperidiin-3-üül)metüülamiini optiline lahutamine ja selle kasutamine pürrolo-2,3-pürimidiini derivaatide kui proteiinikinaasi inhibiitorite valmistamiseks | |
| CL2004000234A1 (es) | Compuestos derivados 3-(piridin-2-il)-4-heteroaril-pirazol sustituidos, antagonistas de aik5 y/o aik4; composicion farmaceutica y uso del compuesto en el tratamiento de desordenes fibroticos como esclerodermia, lupus nefritico, cicatrizacion de herid | |
| CR8847A (es) | Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y usos de los mismos | |
| CR8642A (es) | Compuestos, composiciones farmaceuticas y metodos para su uso en el tratameinto de desordenes metabolicos | |
| IL163613A (en) | Partial or full agonists of a1 adenosine receptors and pharmaceutical compositions comprising the same | |
| ITMI20031570A1 (it) | Composizione per uso dietetico, farmaceutico o cosmetico | |
| CL2004001678A1 (es) | Compuestos derivados de oxazolidinona; composicion farmaceutica; y uso de los compuestos como agentes bacterianos. | |
| CL2007003672A1 (es) | Compuestos derivados de heteroaril-pirrolidinil-cetona y heteroaril-piperidinil-cetona; composicion farmaceutica; y uso en el tratamiento de la depresion y ansiedad. | |
| DK1877409T3 (da) | Substituerede pyrrolopyridiner, sammensætninger, der indeholder samme, fremgangsmåde til fremstilling deraf samt anvendelse deraf | |
| BR0007864A (pt) | Composto, e, uso de um composto | |
| BRPI0812766A2 (pt) | 4-cloro-4-alcóxi-1,1,1-triflúor-2-butanonas, preparação das mesmas e uso das mesmas no preparo de 4-alcóxi-1,1,1-triflúor-3-buten-2-onas | |
| CL2007003198A1 (es) | Compuestos diarilicos opcionalmente nitrogenados, antagonistas de los receptores opioides; composicion farmaceutica; y uso en el tratamiento de la obesidad. | |
| BRPI0506858A (pt) | composto, métodos de preparação de monoidrato de gaboxadol cristalino e de anidrato de gaboxadol cristalino, composição farmacêutica, e, uso de um composto | |
| DK1218380T3 (da) | Bicykliske imidazo-3-yl-aminoderivater substitueret i seksledsringen |